Search results for

UK firm Lovell White Durrant has expanded its Chicago practice with the appointment of six lawyers over the last three months. Anne Fortney is the latest to join the niche reinsurance practice, becoming of counsel. She leaves the Washington DC office of Carlsmith Ball Wichman Case & Ichiki, where she was a partner. "Anne is clearly quite a catch," says a Lovell spokesperson. Neal Moglin has also joined the firm as of counsel from rival Kaplan & Begy. Linda Dublow joins from Streich Lang in Chicago; James Chareq from Stuart & Branigin in Indiana; Markus Heyder from Latham & Watkins in Chicago; and Philip Bock from Chicago firm Lord, Bissel & Brook.

International Trade and Legal Services

US firm White & Case is setting up a trade finance and commodity practice in London. Nicholas Budd, partner at the firm's Paris office, will head the group, which was first launched in France.

On January 1 1997 a number of amendments to the Federal Act on Debt Collection and Insolvency of 1889 entered into force. The amendments are aimed at updating and clarifying the Act, without changing its structure. In the field of injunctions to freeze assets as a provisional remedy, three major modifications have been enacted with a view to improve the protection for the debtor and the third party holder of assets:

With less than five months to go before it returns to Chinese control, Hong Kong is enjoying a surge in the property and securities markets as well as in the overall economy. Confidence is running high. Paul Lee reports

Garrett & Co, the UK firm linked to big six accountant Arthur Andersen, is continuing its expansion by opening a new office in Cambridge. Gerry Fitzsimmons is managing partner. He joins from rival Taylor Vinters's Cambridge office, where he headed the commercial department. The office is hoping to recruit five lawyers who specialize in corporate finance, intellectual property or employment law. "Cambridge is an increasingly exciting place to practise these areas," explains Fitzsimmons. "There is scope here for a quality national practice. There are a lot of science companies which are growing very fast in the local marketplace." He dismisses the competition, saying: "There aren't any national firms here, and we are recruiting aggressively." The firm now has six offices in the UK.

City firm Cameron Markby Hewitt and rival McKenna & Co have ended months of speculation by announcing that they are to merge. On December 17 the firms issued a statement that a new firm, Cameron McKenna, will open on May 1 1997. The firms elected Bill Shelford, senior partner of Cameron Markby Hewitt, as senior partner of the new firm. Managing partner will be Robert Derry-Evans, now managing partner of McKenna. The firm will be the eighth largest in the UK, with nine international offices. The firm will specialize in banking, property, corporate insurance, projects and commercial law.

Austria's largest bank, Bank Austria, outbid three rivals to acquire a 70% stake in Creditanstalt, the country's second biggest bank. The Austrian government has been trying to privatize the stake for six years. The bank paid Sch17.2 billion (US$1.55 billion) for the stake. Bank Austria is now making a partial cash offer of a minimum Sch772 per share to Creditanstalt's minority shareholders and giving them the opportunity to convert the rest of their shares into Bank Austria equity.

Dutch financial services company Aegon is buying the insurance operations of Providian Corporation in a US$2.62 billion stock transaction. It is the largest acquisition in the life insurance industry.

On December 6 1996, the ECJ issued one of the most important rulings in recent years in the continuing battle between pharmaceutical companies and 'parallel importers', ie independent traders who are able to undercut prices in expensive markets by importing bulk quantities of medicines from low-price EU countries. The Primecrown case upholds the right of parallel importers under the Single Market rules to buy and sell wherever they choose in the EU and fails to answer the claim of patent holders that parallel imports threaten research.